The hepatitis A, B and C virus can cause inflammation of the liver. Without treatment the virus can progress to scarring or liver cancer.

Currently there are effective vaccination for Hepatitis A and Hepatitis B. Recent advances in Hepatitis C treatments means easier treatment schedules, fewer side effects and the potential to clear the virus for up to 95% of people of those on treatment. Inclusion of new hepatitis C mediation onto the Pharmaceutical Benefits Scheme (PBS) means increased accessibility for all Australians with Hepatitis C.

Treatment for Hepatitis C can clear the virus for 95% of people.

The hepatitis A virus can cause inflammation of the liver. Without treatment the virus can progress to scarring or liver cancer.

Currently there is effective vaccination for Hepatitis A.

The hepatitis B virus can cause inflammation of the liver. Without treatment the virus can progress to scarring or liver cancer.

Currently there is effective vaccination for Hepatitis B.

The hepatitis C virus can cause inflammation of the liver. Without treatment the virus can progress to scarring or liver cancer.

Recent advances in Hepatitis C treatments means easier treatment schedules, fewer side effects and the potential to clear the virus for up to 95% of people of those on treatment. Inclusion of new hepatitis C mediation onto the Pharmaceutical Benefits Scheme (PBS) means increased accessibility for all Australians with Hepatitis C.